The Krever Commission — 10 years later

On Nov. 25, 1997, Justice Horace Krever released his landmark report on how Canada's blood system managed the threat of HIV and hepatitis C transmission from blood transfusions.[1][1] The tainted blood tragedy, as it came to be called, was arguably the largest public health catastrophe in this

[1]  L. Eggertson.  Lancet publisher to sell arms business , 2007, Canadian Medical Association Journal.

[2]  Pauline Comeau.  Canadian Blood Services to screen for Chagas disease , 2007, Canadian Medical Association Journal.

[3]  C. Beach,et al.  Health Services Restructuring in Canada: New Evidence and New Directions , 2007 .

[4]  A. Laupacis,et al.  Variant Creutzfeldt–Jakob disease and the Canadian blood system after the tainted blood tragedy , 2006, Social Science & Medicine.

[5]  Blood donor screening for chagas disease--United States, 2006-2007. , 2007, MMWR. Morbidity and mortality weekly report.

[6]  S. Kleinman,et al.  The development of West Nile virus safety policies by Canadian blood services: guiding principles and a comparison between Canada and the United States. , 2006, Transfusion medicine reviews.

[7]  M. Turner,et al.  Managing the risk of transmission of variant Creutzfeldt Jakob disease by blood products , 2006, British journal of haematology.

[8]  J Mackenzie,et al.  Creutzfeldt-Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study. , 2006, Vox sanguinis.

[9]  S. Sandler.  The case for pathogen inactivation of blood components , 2005 .

[10]  K. Wilson,et al.  Understanding the Impact of Intergovernmental Relations on Public Health: Lessons from Reform Initiatives in the Blood System and Health Surveillance , 2004 .

[11]  J Mackenzie,et al.  Possible transmission of variant Creutzfeldt-Jakob disease by blood transfusion , 2004, The Lancet.

[12]  R. Lanciotti,et al.  Transmission of West Nile virus through blood transfusion in the United States in 2002. , 2003, The New England journal of medicine.

[13]  K. Wilson,et al.  The challenge of an increasingly expensive blood system. , 2003, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[14]  M. Postma,et al.  Pharmaco‐economics of blood transfusion safety: review of the available evidence , 2002, Vox sanguinis.

[15]  E. Read,et al.  Trypanosoma cruzi in Los Angeles and Miami blood donors: impact of evolving donor demographics on seroprevalence and implications for transfusion transmission , 2002, Transfusion.

[16]  A. Laupacis,et al.  A policy analysis of major decisions relating to Creutzfeldt-Jakob disease and the blood supply. , 2001, CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne.

[17]  R. Will,et al.  Creutzfeldt–Jakob disease and blood transfusion: results of the UK Transfusion Medicine Epidemiological Review study , 2006, BMJ.